Cargando…
Clinical Features and Treatment Outcomes of Primary Immune Thrombocytopenic Purpura in Hospitalized Children Under 2-Years Old
BACKGROUND: Immune thrombocytopenic purpura (ITP) is the most prevalent cause of thrombocytopenia in children. Despite the importance of ITP in children under 2-years old, only a few publications are available in the literature.ITP usually presents itself as isolated thrombocytopenia and mucocutaneo...
Autores principales: | Farhangi, H, Ghasemi, A, Banihashem, A, Badiei, Z, Jarahi, L, Eslami, G, Langaee, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shahid Sadoughi University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867168/ https://www.ncbi.nlm.nih.gov/pubmed/27222699 |
Ejemplares similares
-
Immune thrombocytopenic purpura
por: Zainal, Abir, et al.
Publicado: (2019) -
Dapsone therapy for immune thrombocytopenic purpura: old but still unfamiliar
por: Song, Jaewoo
Publicado: (2017) -
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023) -
Daratumumab for immune thrombotic thrombocytopenic purpura
por: van den Berg, Jana, et al.
Publicado: (2022) -
Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report
por: Ge, Hangping, et al.
Publicado: (2022)